“Whistleblower” Suits Should Be Encouraged By Rx Manufacturers, Sen. Grassley Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Schering-Plough’s Claritin settlement prompts letter from Grassley to Schering and 18 other manufacturers. Educating employees about the False Claims Act and their right to file suit is a “step in the right direction” to address fraud, he says.